<DOC>
	<DOC>NCT00565162</DOC>
	<brief_summary>To introduce initiation of glargine insulin treatment in primary care based on a patient education program. To show and compare feasibility of group education to individual education program.</brief_summary>
	<brief_title>Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Insulinnaive Type 2 Diabetes Mellitus subjects, aged â‰¥18 years and on stable oral antidiabetic treatment for &gt;6 months requiring basal longacting insulin (HbA1c &gt;7.5 % and &lt;12.0 %). The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>